2025 Journal Article Marginal cytokine modulation by Schistosoma mansoni soluble egg antigen in SARS-CoV-2-infected K18-hACE2 miceMu, Yi, Yan, Kexin, McManus, Donald P., Nguyen, Wilson, Rawle, Daniel J., Roberts, Jason A., Jones, Malcolm K. and Cai, Pengfei (2025). Marginal cytokine modulation by Schistosoma mansoni soluble egg antigen in SARS-CoV-2-infected K18-hACE2 mice. Folia Parasitologica, 72 019, 72. doi: 10.14411/fp.2025.019 |
2025 Journal Article Beta-lactam antibiotic administration in critically ill children with sepsis: an international survey of current practiceRaman, Sainath, Reddy, Rayna, de Souza, Daniela Carla, Cox, Renee, Le Marsney, Renate, Nallasamy, Karthi, Ramnarayan, Padmanabhan, Roberts, Jason A., Schlapbach, Luregn J., Gibbons, Kristen S., the Australian and New Zealand Intensive Care Society Paediatric Study Group, Kerig, Tatjana, Darvas, Jennifer, Festa, Marino, George, Shane, Balit, Corrine, Oberender, Felix, Erickson, Simon, Flores, Jenipher Chumbes, Charles, Karina, Waak, Michaela, Long, Debbie, Butt, Warwick, Delzoppo, Carmel, Gelbart, Ben, Masterson, Kate, Millar, Johnny, Ganeshalingam, Anusha, Sherring, Claire ... Smith, Vicky (2025). Beta-lactam antibiotic administration in critically ill children with sepsis: an international survey of current practice. Intensive Care Medicine – Paediatric and Neonatal, 3 (1) 18. doi: 10.1007/s44253-025-00075-4 |
2025 Journal Article Current practices in outpatient parenteral antimicrobial therapy programmes: an international multi-centre surveyWolie, Zenaw T., Roberts, Jason A., López-Cortés, Luis Eduardo, Mirón-Rubio, Manuel, Pollard, James, Marizan Nor, Afra Nahdia, Abdul-Aziz, Mohd H., Jamieson, Conor, Seaton, R Andrew, Gilchrist, Mark and Sime, Fekade B. (2025). Current practices in outpatient parenteral antimicrobial therapy programmes: an international multi-centre survey. JAC - Antimicrobial Resistance, 7 (3) dlaf075, 1-11. doi: 10.1093/jacamr/dlaf075 |
2025 Journal Article Population pharmacokinetics of intravenous fosfomycin: dose optimization for critically ill patients with and without kidney replacement therapyGoetz, Katharina M., Kreuer, Sascha, Volz, Anke-Katrin, Parker, Suzanne L., Roberts, Jason A., Dimopoulos, George, Dimski, Thomas, Kindgen-Milles, Detlef, Beuche, Lisa K. V., Kielstein, Jan T. and Lehr, Thorsten (2025). Population pharmacokinetics of intravenous fosfomycin: dose optimization for critically ill patients with and without kidney replacement therapy. Antimicrobial Agents and Chemotherapy, 69 (6), e0177924. doi: 10.1128/aac.01779-24 |
2025 Journal Article Optimization of antimicrobial therapy in critically ill patients, What Clinicians and Searchers Must KnowRoger, Claire, Koulenti, Despoina, Novy, Emmanuel, Roberts, Jason and Dahyot-Fizelier, Claire (2025). Optimization of antimicrobial therapy in critically ill patients, What Clinicians and Searchers Must Know. Anaesthesia Critical Care & Pain Medicine 101561, 101561. doi: 10.1016/j.accpm.2025.101561 |
2025 Journal Article A Global Survey of Diagnostic Practices in Prosthetic Joint InfectionsSubedi, Shradha, Harris, Patrick NA, Chapman, Paul, Chen, Antonia F, Davis, Joshua S, Liu, Po-Yu, Marais, Leonard C, Salles, Mauro J, Roberts, Jason A, Rodriguez-Bano, Jesus, Wouthuyzen-Bakker, Marjan, Paterson, David L and Benito, Natividad (2025). A Global Survey of Diagnostic Practices in Prosthetic Joint Infections. Diagnostic Microbiology and Infectious Disease, 113 (2) 116919, 116919-2. doi: 10.1016/j.diagmicrobio.2025.116919 |
2025 Journal Article Evaluation of the stability of tigecycline in elastomeric infusion devices used for outpatient parenteral antimicrobial therapyWolie, Zenaw T, Unwin, Sean, Burke, Andrew, Won, Hayoung, Wallis, Steven C, Seaton, R Andrew, Gilchrist, Mark, Roberts, Jason A and Sime, Fekade B (2025). Evaluation of the stability of tigecycline in elastomeric infusion devices used for outpatient parenteral antimicrobial therapy. JAC-Antimicrobial Resistance, 7 (3) dlaf074, dlaf074-3. doi: 10.1093/jacamr/dlaf074 |
2025 Journal Article Population Pharmacokinetic Modelling of Remdesivir and Its Metabolite GS-441524 in Hospitalised Patients with COVID-19Roberts, Darren M., Liu, Xin, Parker, Suzanne L., Burke, Andrew, Peek, Jenny, Carland, Jane E., Murnion, Bridin, Seah, Vincent, Wallis, Steven C., Sumi, Chandra D., Pandey, Saurabh, Buscher, Hergen, Byrne, Anthony, Sandaradura, Indy, Bowen, David, Holz, Simon, Stewart, Adam G., Hajkowicz, Krispin M. and Roberts, Jason A. (2025). Population Pharmacokinetic Modelling of Remdesivir and Its Metabolite GS-441524 in Hospitalised Patients with COVID-19. Clinical Pharmacokinetics, 64 (5) e0022222, 1-14. doi: 10.1007/s40262-025-01496-2 |
2025 Journal Article Correction of posaconazole concentrations for hypoalbuminemiaNix, David E., Sime, Fekade and Roberts, Jason A. (2025). Correction of posaconazole concentrations for hypoalbuminemia. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 45 (6), 324-331. doi: 10.1002/phar.70021 |
2025 Journal Article A Systematic Review of Pharmacokinetic Studies of Colistin and Polymyxin B in Adult PopulationsZamri, Puteri Juanita, Lim, Sazlyna Mohd Sazlly, Sime, Fekade Bruck, Roberts, Jason A. and Abdul-Aziz, Mohd Hafiz (2025). A Systematic Review of Pharmacokinetic Studies of Colistin and Polymyxin B in Adult Populations. Clinical Pharmacokinetics, 64 (5) n71, 1-35. doi: 10.1007/s40262-025-01488-2 |
2025 Journal Article The FUSION Study: compatibility of antibiotics with commonly used medication infusions in a paediatric intensive care unitTu, Quyen, Won, Hayoung, Sime, Fekade Bruck, Raman, Sainath, Cotta, Menino Osbert, Wallis, Steven C., Marjanovic, Dusan, Stacey, Sonya, Schlapbach, Luregn and Roberts, Jason A. (2025). The FUSION Study: compatibility of antibiotics with commonly used medication infusions in a paediatric intensive care unit. European Journal of Hospital Pharmacy ejhpharm-2024-004450, ejhpharm-2024. doi: 10.1136/ejhpharm-2024-004450 |
2025 Journal Article Optimising peri-operative intravenous lidocaine dosing regimensTognolini, Angela, Roberts, Jason A. and Eley, Victoria A. (2025). Optimising peri-operative intravenous lidocaine dosing regimens. Anaesthesia, 80 (7), 873-873. doi: 10.1111/anae.16611 |
2025 Journal Article Pharmacokinetics of Metronidazole During Prolonged Intermittent Kidney Replacement TherapyXu, Jessica H., Cheng, Vesa, Rawlins, Matthew, Morgan, David, Won, Hayoung, Wu, Xiaolin, Dyer, John and Roberts, Jason A. (2025). Pharmacokinetics of Metronidazole During Prolonged Intermittent Kidney Replacement Therapy. Hemodialysis International. doi: 10.1111/hdi.13242 |
2025 Journal Article Quantifying cost savings from outpatient parenteral antimicrobial therapy programme: a systematic review and meta-analysisMohammed, Solomon Ahmed, Roberts, Jason A., Mirón-Rubio, Manuel, López Cortés, Luis Eduardo, Assefa, Getnet Mengistu, Pollard, James, McCarthy, Kate, Gilchrist, Mark, Cotta, Menino and Sime, Fekade B. (2025). Quantifying cost savings from outpatient parenteral antimicrobial therapy programme: a systematic review and meta-analysis. JAC-Antimicrobial Resistance, 7 (2) dlaf049, 1-11. doi: 10.1093/jacamr/dlaf049 |
2025 Journal Article Optimizing ICU antifungal therapy: overcoming pharmacokinetic limitations with combination strategies—author's replyHernández-Mitre, María Patricia, Roberts, Jason A. and Roger, Claire (2025). Optimizing ICU antifungal therapy: overcoming pharmacokinetic limitations with combination strategies—author's reply. Intensive Care Medicine, 51 (4), 1-2. doi: 10.1007/s00134-025-07872-7 |
2025 Journal Article Cefazolin versus placebo for surgical antibiotic prophylaxis in low-risk cesarean delivery: a feasibility blinded randomized controlled trialEley, Victoria A., Navarro, Severine, Martin, Elizabeth, Amoako, Akwasi, Hartel, Gunter, Woods, Christine, Lu, Yan, Lipman, Jeffrey, Roberts, Jason, Tang, Mimi and Callaway, Leonie (2025). Cefazolin versus placebo for surgical antibiotic prophylaxis in low-risk cesarean delivery: a feasibility blinded randomized controlled trial. BMC Pregnancy and Childbirth, 25 (1) 353, 353. doi: 10.1186/s12884-025-07484-5 |
2025 Journal Article Population pharmacokinetics and dosing simulations of temocillin in liver-transplanted paediatric patients: a prospective, open-label, non-randomized studyNgougni Pokem, Perrin, Stéphenne, Xavier, Liu, Xin, Parker, Suzanne L., Van der Linden, Dimitri, Godet, Marie-Laura, Wijnant, Gert-Jan, Chatzis, Olga, Houtekie, Laurent, Haenecour, Astrid, Sokal, Etienne, Roberts, Jason A., Elens, Laure and Van Bambeke, Françoise (2025). Population pharmacokinetics and dosing simulations of temocillin in liver-transplanted paediatric patients: a prospective, open-label, non-randomized study. Clinical Microbiology and Infection, 31 (3), 408-416. doi: 10.1016/j.cmi.2024.12.015 |
2025 Journal Article In reply to the Letter to Editor regarding ‘Renal function and its impact on the concentration of ceftazidime-avibactam: A cross-sectional study’Angelini, Jacopo, Giuliano, Simone, Lanini, Simone, Ferin, Sara, Martini, Luca, Cossettini, Stella, Roberts, Jason, Baraldo, Massimo and Tascini, Carlo (2025). In reply to the Letter to Editor regarding ‘Renal function and its impact on the concentration of ceftazidime-avibactam: A cross-sectional study’. International Journal of Antimicrobial Agents, 65 (6) 107480, 107480. doi: 10.1016/j.ijantimicag.2025.107480 |
2025 Journal Article Statistical documentation for multi-disease, multi-domain platform trials: our experience with the Staphylococcus aureus Network Adaptive Platform trialMahar, Robert K., McGlothlin, Anna, Dymock, Michael, Barina, Lauren, Bonten, Marc, Bowen, Asha, Cheng, Matthew P., Daneman, Nick, Goodman, Anna L., Lee, Todd C., Lewis, Roger J., Lumley, Thomas, McLean, Alistair R. D., McQuilten, Zoe, Mora, Jocelyn, Paterson, David L., Price, David J., Roberts, Jason, Snelling, Tom, Tverring, Jonas, Webb, Steve A., Yahav, Dafna, Davis, Joshua S., Tong, Steven Y. C., Marsh, Julie A., on behalf of the SNAP Global Trial Steering Committee, Boyles, Tom, Cosgrove, Catherine, Heriot, George ... Whiteway, Lynda (2025). Statistical documentation for multi-disease, multi-domain platform trials: our experience with the Staphylococcus aureus Network Adaptive Platform trial. Trials, 26 (1) 49, 1-7. doi: 10.1186/s13063-024-08684-8 |
2025 Journal Article Are contemporary antifungal doses sufficient for critically ill patients? Outcomes from an international, multicenter pharmacokinetics study for Screening Antifungal Exposure in Intensive Care Units—the SAFE-ICU studyRoberts, Jason A., Sime, Fekade B., Lipman, Jeffrey, Hernández-Mitre, María Patricia, Baptista, João Pedro, Brüggemann, Roger J., Darvall, Jai, De Waele, Jan J., Dimopoulos, George, Lefrant, Jean-Yves, Mat Nor, Mohd Basri, Rello, Jordi, Seoane, Leonardo, Slavin, Monica A., Valkonen, Miia, Venditti, Mario, Ceccarelli, Giancarlo, Wong, Wai Tat, Zeitlinger, Markus and Roger, Claire (2025). Are contemporary antifungal doses sufficient for critically ill patients? Outcomes from an international, multicenter pharmacokinetics study for Screening Antifungal Exposure in Intensive Care Units—the SAFE-ICU study. Intensive Care Medicine, 51 (2), 1-16. doi: 10.1007/s00134-025-07793-5 |